-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on Stryker, Lowers Price Target to $340

Benzinga·10/31/2026 00:11:02
Diffusion vocale
JP Morgan analyst Robbie Marcus maintains Stryker (NYSE:SYK) with a Overweight and lowers the price target from $350 to $340.